13

ILEOCECAL RESECTION FOR RECENTLY DIAGNOSED ILEOCECAL CROHN’S DISEASE IS ASSOCIATED WITH IMPROVED LONG-TERM OUTCOMES COMPARED TO ANTI-TUMOR NECROSIS FACTOR THERAPY: A POPULATION-BASED STUDY

Date
May 6, 2023
Explore related products in the following collection:

Loading...

Tracks

Related Products

Thumbnail for SAFETY OF IMMUNOSUPPRESSION IN A PROSPECTIVE COHORT OF INFLAMMATORY BOWEL DISEASE PATIENTS WITH A HISTORY OF CANCER: THE SAPPHIRE REGISTRY
SAFETY OF IMMUNOSUPPRESSION IN A PROSPECTIVE COHORT OF INFLAMMATORY BOWEL DISEASE PATIENTS WITH A HISTORY OF CANCER: THE SAPPHIRE REGISTRY
BACKGROUND AND AIMS: A treat-to-target (TTT) strategy of striving for symptomatic and endoscopic remission is recommended for the management of inflammatory bowel diseases (IBD). Yet, real-world uptake of TTT strategies has been modest…
Thumbnail for VEDOLIZUMAB RESPONSE IN ULCERATIVE COLITIS ASSOCIATES WITH LYMPHOID AGGREGATE ATTENUATION THROUGH IMPAIRED RECRUITMENT OF NAÏVE LYMPHOCYTES
VEDOLIZUMAB RESPONSE IN ULCERATIVE COLITIS ASSOCIATES WITH LYMPHOID AGGREGATE ATTENUATION THROUGH IMPAIRED RECRUITMENT OF NAÏVE LYMPHOCYTES
The pathogenesis of inflammatory bowel disease (IBD) involves crosstalk between genetic and microbial factors that influence immune reactions. Tofacitinib, a pan JAK-STAT inhibitor, is a small molecule indicated for the treatment of moderate-to-severe ulcerative colitis (UC)…
Thumbnail for AGA Patricia and Ralph Giannella Lecture: Road to Prediction: Inflammatory Bowel Disease Risk and Outcomes
AGA Patricia and Ralph Giannella Lecture: Road to Prediction: Inflammatory Bowel Disease Risk and Outcomes
The burden of IBD is rising globally. This session aims to understand the role of genetics in the development of IBD in diverse populations and define the pre-disease state in IBD. It will also explore the emerging field of multi-omics to clinically characterize IBD…
Thumbnail for ANTI-INTEGRIN αVβ6 AUTOANTIBODIES ARE A NOVEL PREDICTIVE BIOMARKER IN ULCERATIVE COLITIS
ANTI-INTEGRIN αVβ6 AUTOANTIBODIES ARE A NOVEL PREDICTIVE BIOMARKER IN ULCERATIVE COLITIS
Aconitate decarboxylase 1 (ACOD1; also known as IRG-1) is the ubiquitous source of the metabolite itaconate, which dampens inflammasome activation by preventing HIF1α production of IL-1β and prevents TNF production through NRF2 activation…